Aziridinylbenzoquinone in recurrent, progressive glioma of the central nervous system. A Phase II study by the Illinois Cancer Council.

M Haid; J D Khandekar; M Christ; C M Johnson; S J Miller; G Y Locker; J M Merrill; H Reisel; A Hatfield; V Lanzotti

doi:10.1002/1097-0142(19850915)56:6<1311::aid-cncr2820560615>3.0.co;2-v

Aziridinylbenzoquinone in recurrent, progressive glioma of the central nervous system. A Phase II study by the Illinois Cancer Council.

Identifier:nobleid.org/w1/20260515/A956ABC3

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/A956ABC3.svg?ark=w1%2F20260515%2FA956ABC3)](https://nobleid.org/work/w1/20260515/A956ABC3)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Aziridinylbenzoquinone in recurrent, progressive glioma of the central nervous system. A Phase II study by the Illinois Cancer Council.

Identifier:nobleid.org/w1/20260515/A956ABC3

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/A956ABC3.svg?ark=w1%2F20260515%2FA956ABC3)](https://nobleid.org/work/w1/20260515/A956ABC3)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work